NDC 0143-9771

Ondansetron Hydrochloride and Dextrose

Ondansetron Hydrochloride And Dextrose

Ondansetron Hydrochloride and Dextrose is a Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by West-ward Pharmaceutical Corp. The primary component is Ondansetron Hydrochloride.

Product ID0143-9771_b81ba160-bb0d-4d28-a191-20d2cd646bea
NDC0143-9771
Product TypeHuman Prescription Drug
Proprietary NameOndansetron Hydrochloride and Dextrose
Generic NameOndansetron Hydrochloride And Dextrose
Dosage FormInjection, Solution
Route of AdministrationINTRAVENOUS
Marketing Start Date2009-08-04
Marketing CategoryANDA / ANDA
Application NumberANDA078308
Labeler NameWest-ward Pharmaceutical Corp
Substance NameONDANSETRON HYDROCHLORIDE
Active Ingredient Strength32 mg/50mL
Pharm ClassesSerotonin 3 Receptor Antagonists [MoA],Serotonin-3 Receptor Antagonist [EPC]
NDC Exclude FlagE
Listing Certified Through2017-12-31

Packaging

NDC 0143-9771-06

6 BAG in 1 CASE (0143-9771-06) > 50 mL in 1 BAG
Marketing Start Date2009-08-04
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 0143-9771-06 [00143977106]

Ondansetron Hydrochloride and Dextrose INJECTION, SOLUTION
Marketing CategoryANDA
Application NumberANDA078308
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2009-08-04
Inactivation Date2019-10-21

Drug Details

Active Ingredients

IngredientStrength
ONDANSETRON HYDROCHLORIDE32 mg/50mL

OpenFDA Data

SPL SET ID:693ba38b-4cbe-4a6a-9c80-b9d2f554edce
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 312083
  • Pharmacological Class

    • Serotonin 3 Receptor Antagonists [MoA]
    • Serotonin-3 Receptor Antagonist [EPC]

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.